Presenter: G. Velikova
Professor of Psychosocial and Medical Oncology, University of Leeds / Honorary Consultant in Medical Oncology, Leeds Teaching Hospitals NHS Trust. Professor Velikova graduated from the Medical Institute, Varna, Bulgaria in 1986. She obtained a specialty degree in Internal Medicine in Bulgaria in 1994. Then she moved to UK and completed specialist training in Medical Oncology in 2001. She obtained a PhD from the University of Leeds 2001 for a research degree project Quality of life measurement in daily oncology practice. Professor Velikova leads a research group funded by a Cancer Research UK programme grant in psychosocial oncology to study the implementation of routine measurement of patient-reported outcomes and quality of life in oncology practice. She was also involved in the successful bid to host one of the National Cancer Research Institute (NCRI) Supportive and Palliative Care Research Collaboratives. Current research, funded by National Institute for Health Research in UK, also includes development of a web-based electronic system for collecting patient reported data on toxicity and adverse events during cancer treatment, integrating this with electronic patient records and generating alerts for clinicians. She is a Consultant in Medical Oncology and a Professor at the University of Leeds. Her clinical work focuses on systemic treatment of breast cancer patients. She leads the quality of life sub-studies of large national and international research trials in breast cancer, including TACT2 and SUPREMO. She is also the local lead for the national D-CARE trial. She is involved in the implementation in NHS, locally of holistic assessment for cancer patients (NICE supportive & palliative care guidelines) & nationally contributes to the National Cancer Survivorship Initiative. Professor Velikova was chair of the British Psychosocial Oncology Society (BPOS) until the end of 2010 and she is a member of the UK National Cancer Research Institute Psychosocial Oncology Clinical Studies Development Group, chairing its sub group on the impact of side effects of treatments and interventions. She was the chair of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group until September 2011 and a former Board member of the International Society for Quality of Life Research (ISOQOL).
|University:||University of Leeds|
|Biomedexperts:||Open profile on biomedexperts.com|
|Pubmed:||Open pubmed profile|
|Department/Institute:||St James Institute of Oncology|
|Address:||Section of Oncology and Clinical Research|
|City:||Leeds, LS9 7TF, UK|